Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Metastatic HER2 Positive Gastroesophageal Junction Cancer × disitamab vedotin × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Ovarian Neoplasms 1 Muscle Invasive Bladder Cancer (MIBC) 1 Head and Neck Neoplasms 1 HER2-low Breast Cancer 1 Endometrial Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡